"In the nascent RNA-targeting small molecule space, the RNA Assay Development & Screening Summit provides an important opportunity for players across the small molecule space to compare notes on what’s working and not in the early discovery phase."

Chuhern Hwang, Co-Founder & Head of Drug Discovery, Wayfinder Biosciences

"I see great value in this meeting, particularly as an opportunity to share our experiences in the emerging field of RNA targeting by small molecules. This area of therapeutics is still very explorative, so it is fun meeting the people, who have the courage to build new expertise."

Kasia Drzewicka, Senior Scientist, Molecure

“It’s a great forum to meet academic and industry leaders in the RNA field and an opportunity to network and share experiences, challenges, and new developments.”

Balajee Somalinga, Director, RNA Biology, CHDI Management

“It’s an important opportunity to observe your peers work and approaches. In such a young field, sharing ideas and experience is essential to moving the field forward.”

Benjamin Brigham, Senior Scientist, Atavistik Bio

“This meeting will highlight contemporary methods from scientists of diverse backgrounds and expertise to study and target RNA biology.”

Ku-Lung (Ken) Hsu, Associate Professor, University of Texas at Austin

“The Meeting will be a great opportunity to discuss our needs and challenges in RNA-oriented research. I hope to share ideas and find new scientific friendships and collaborations.”

Martyna Nowacka, Senior Scientist, Molecure

“This conference will be a highly valuable platform to share solutions and challenges to further advance the field of RNA as drug targets for small molecules”

Stefan Schiesser, Director, Medicinal Chemistry, AstraZeneca